Friday, December 28, 2018

A look at how Cipla is trying to consolidate its position in respiratory segment

A look at how Cipla is trying to consolidate its position in respiratory segment Cipla sells a range of products including pills, nasal sprays and inhalers to treat respiratory diseases.

from Moneycontrol Business News http://bit.ly/2GWCpPJ

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...